Claudia Mendoza-Pinto1,2, Mario García-Carrasco1,2, Ricard Cervera3. 1. Systemic Autoimmune Diseases Research Unit, UMAE CMN Manuel Avila Camacho, Instituto Mexicano del Seguro Social, Puebla, Mexico. 2. Immunology and Rheumatology, Medical School, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico. 3. Department of Autoimmune Diseases, Hospital Clinic, Villarroel, 170, 08036, Barcelona, Catalonia, Spain. rcervera@clinic.cat.
Abstract
PURPOSE OF REVIEW: The antiphospholipid syndrome (APS) is characterized by the development of thrombotic events and pregnancy morbidity in the presence of antiphospholipid antibodies (aPL). An infectious etiology for this syndrome has been postulated. The present review is aimed to summarize recent evidence about the role of infections and vaccines in the pathogenesis of the APS (including its catastrophic variant). RECENT FINDINGS: There is an increased risk of developing aPL in various infections, particularly in viral infections. The most frequent infection related to aPL has been hepatitis C virus. These antibodies may be associated with thromboembolic events, including catastrophic APS. There is a link between vaccinations, such as the tetanus toxoid and aPL, due to molecular mimicry between the two molecules. Accumulated evidence supports that the presence of aPL is associated with a variety of infections, including viruses, bacteria, fungi, and parasites, and the main mechanism to explain this correlation is molecular mimicry. Moreover, a link between vaccinations, such as the tetanus toxoid, and APS has also been described.
PURPOSE OF REVIEW: The antiphospholipid syndrome (APS) is characterized by the development of thrombotic events and pregnancy morbidity in the presence of antiphospholipid antibodies (aPL). An infectious etiology for this syndrome has been postulated. The present review is aimed to summarize recent evidence about the role of infections and vaccines in the pathogenesis of the APS (including its catastrophic variant). RECENT FINDINGS: There is an increased risk of developing aPL in various infections, particularly in viral infections. The most frequent infection related to aPL has been hepatitis C virus. These antibodies may be associated with thromboembolic events, including catastrophic APS. There is a link between vaccinations, such as the tetanus toxoid and aPL, due to molecular mimicry between the two molecules. Accumulated evidence supports that the presence of aPL is associated with a variety of infections, including viruses, bacteria, fungi, and parasites, and the main mechanism to explain this correlation is molecular mimicry. Moreover, a link between vaccinations, such as the tetanus toxoid, and APS has also been described.
Authors: Gabriela Medina; Eduardo Briones-García; María Pilar Cruz-Domínguez; Oscar I Flórez-Durante; Luis J Jara Journal: Autoimmun Rev Date: 2017-02-13 Impact factor: 9.754
Authors: L Cotticelli; M Borrelli; A C D'Alessio; M Menzione; A Villani; G Piccolo; F Montella; M R Iovene; M Romano Journal: Eur J Ophthalmol Date: 2006 Mar-Apr Impact factor: 2.597
Authors: J Ordi-Ros; A Selva-O'Callaghan; F Monegal-Ferran; Y Monasterio-Aspiri; C Juste-Sanchez; M Vilardell-Tarres Journal: Clin Infect Dis Date: 1994-02 Impact factor: 9.079
Authors: Dirk Roggenbuck; Maria Orietta Borghi; Valentina Somma; Thomas Büttner; Peter Schierack; Katja Hanack; Claudia Grossi; Caterina Bodio; Paolo Macor; Philipp von Landenberg; Francesco Boccellato; Michael Mahler; Pier Luigi Meroni Journal: Arthritis Res Ther Date: 2016-05-21 Impact factor: 5.156
Authors: Rubens Carmo Costa-Filho; Hugo Caire Castro-Faria Neto; José Mengel; Marcelo Pelajo-Machado; Marco Aurélio Martins; Érica Távora Leite; Hugo Tannus Mendonça-Filho; Tatiana de Arruda Campos Brasil de Souza; Gonzalo Bentacor Bello; José Paulo Gagliardi Leite Journal: Mem Inst Oswaldo Cruz Date: 2021-04-30 Impact factor: 2.743